Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Grows By 359.0%

Nanovibronix, Inc. (NASDAQ:FEED) saw a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 344,075 shares, a growth of 359.0% from the July 30th total of 74,962 shares. Currently, 3.5% of the shares of the company are sold short. Based on an average trading volume of 3,043,455 shares, the days-to-cover ratio is presently 0.1 days.

Nanovibronix Stock Performance

NASDAQ:FEED traded up $0.00 during trading hours on Wednesday, reaching $0.39. The company’s stock had a trading volume of 37,925 shares, compared to its average volume of 5,333,309. The firm has a market capitalization of $4.30 million, a price-to-earnings ratio of -0.04 and a beta of 1.38. The firm has a 50-day simple moving average of $0.46 and a 200-day simple moving average of $1.24. Nanovibronix has a 1 year low of $0.29 and a 1 year high of $17.40.

Nanovibronix (NASDAQ:FEED) last issued its earnings results on Monday, August 17th. The company reported ($1.98) earnings per share (EPS) for the quarter. Nanovibronix had a negative return on equity of 60.73% and a negative net margin of 1,093.61%.The firm had revenue of $0.24 million during the quarter.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on FEED shares. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research report on Tuesday, July 21st. Wall Street Zen raised Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Sunday, July 12th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Nanovibronix presently has an average rating of “Sell”.

Insiders Place Their Bets

In other news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 12.20% of the company’s stock.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.